Category Archive

The following is a list of all entries from the General category.

Need Money, Will Warn of Dangerous Drugs

The FDA was once identified as a gold standard of government agencies, taking its responsibility to the public safety very seriously. It was a key player in mitigating some potentially disastrous events in our short pharmaceutical history, as I explored in, “A Brief FDA History Lesson.” In recent months, however, it has come [...]


Personal Doctor in my Pill

You may remember my article about Swiss experimentation with Microbots and their potential for use in new surgical procedures in the future. Being a technology professional, I’m amazed when we can identify ways to leverage technology to make things smaller or to make smaller things do more. Along those lines, I was fascinated [...]


A Rose By Any Other Name Could Be Depression

A few weeks ago I was on a train headed into New York City for a meeting. Somewhere nearby, there was an overpowering smell of roses, and judging from the lack of flowers in any of the seats I surmised that it was someone’s perfume I was smelling. Generally, a scent like that [...]


Top 7 BioPharm Blog Stories of 2007

Well, I debated for a while as to whether I should do a “top stories” article of 2007. I was going to base it on a comprehensive review of blogs and news articles out there, picking and choosing those stories I agreed with and posting them here. However, with over 50 articles written [...]


Brokeback Pharma

Please note: As some of you may have noticed, we’ve been having some problems getting our blog up on its regular site (http://bpblog.avelient.com) over the last week. This is partially due to some upgrades that are being applied to our blogging software and a new look we’re planning for release soon. As a [...]


Do Pharmaceuticals Drive Medical Knowledge?

I am plagued with insomnia on this cold December night. I managed to sleep about an hour tonight before waking up and tossing in my bed (it didn’t seem to faze my wife, who slept soundly beside me). Unfortunately, I wasn’t destined to have a normal night’s sleep anyway; tomorrow (well, today) I’m [...]


Thanksgiving Lethargy?

As I sat and watched TV on Thursday night after a fantastic Thanksgiving meal, I contemplated Friday’s blog entry and decided not to do it because of the Thanksgiving holiday. Besides, upon awakening on Friday morning, I found myself in a haze, I presumed due to the amino acid tryptophan, something that our body [...]


A Brief FDA History Lesson

Just before a presentation I gave on Monday concerning Virtual Reality and its use in medicine, the group that had assembled was discussing a variety of current topics in the pharmaceutical and biotechnology industries. One of the attendees, Peter Castellano, caught my interest when he described an article he found in the October 2007 [...]


MIT: Building a Better Manufacturing Process for Novartis for $65m

In a Boston Globe article posted today, pharmaceutical giant Novartis announced that it would be contributing $65 million to the Massachusetts Institute of Technology (MIT) over the next 10 years to create a new research program with a goal of improving the current drug manufacturing process with better technology in order to save both time [...]


The Vaccination Debate

I was making myself a snack the other night when I noticed Jenny McCarthy on the TV program my wife happened to be watching. Having not seen her as much in recent years as I did when I was younger, I was curious as to whether she was on a talk show because she [...]